Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a...
Pop Culture Group Co., Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
XIAMEN, China, March 21, 2025 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered in China, today announced that the Company received a notification letter (the...
Kerry Logistics Network Wins Award for Best Sustainability-Linked Loan - Logistics At The Asset Triple A Sustainable Finance Awards 2025
HONG KONG, March 20, 2025 /PRNewswire/ -- Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK) is honoured to receive the Best Sustainability-Linked Loan – Logistics accolade at The Asset Triple A Sustainable Finance Awards 2025 (the...
Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer
SHANGHAI, March 19, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal antibody...
Waterdrop Inc. Receives a 'Buy' Rating from UOB Kay Hian with Price Target of US$2.20
BEIJING, March 19, 2025 /PRNewswire/ -- On March 14, 2025, UOB Kay Hian included Waterdrop Inc. (WDH) for the first time in its most recent report, commenting that the company has built a substantial user base through its strong brand equity and is...
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
HONG KONG, March 17, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National Medical Products Administration (NMPA) for the...
Coway's NOBLE 2.0 Air Purifier Series Receives iF Design Award 2025 for Product Design
Coway's NOBLE 2.0 Air Purifier Series has been honored by the iF International Forum for its sophisticated design and innovative air purification technologies 2025 marks Coway's 18th consecutive year of recognition from the iF Design Award SEOUL,...
Hanwha Aerospace Receives DNV AIP Certification on Hydrogen Fuel Cells
Global Authority DNV Validates Top-Tier Safety and Performance Standards Second Major Certification Following Korean Register Approval Last Year Company Positioned to Advance Zero-Carbon Maritime Propulsion Technology SEOUL, South Korea, March 13,...
Korea Ginseng Corp. (JungKwanJang) Receives 'Tyler Award' from American Botanical Council
- The American Botanical Council (ABC) selects institutions that contribute to scientific research on natural products worldwide. CERRITOS, Calif., March 11, 2025 /PRNewswire/ -- Korea Ginseng Corp. (KGC), known for its flagship brand JungKwanJang,...
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1], [2] The FDA approval is based on robust clinical evidence, which show...